Factors that Determined a Positive Response to Resynchronization Therapy in Patients With Chronic Heart Failure and Cardiac Dyssynchrony. One Center Experience [0.03%]
影响慢性心衰合并心脏不同步患者再同步治疗效果的中心经验分析
A S Postol,N M Neminushchiy,G N Antipov et al.
A S Postol et al.
Aim: To evaluate the efficacy of cardiac resynchronization therapy (CRT) in patients with chronic heart failure (CHF) associated with cardiac dyssynchrony and to identify the factors that influence the CRT efficacy. ...
Utility of Point-of-Care Diagnosis of Chronic Heart Failure Using an Express Test for Semi-Quantitative Determination of NT-proBNP Levels [0.03%]
急诊心力衰竭诊断检测试剂盒的应用价值评估研究半定量检测NT-proBNP水平的快速检測装置用于慢性心力衰竭门诊诊断中
A V Iosifov,O A Shtegman
A V Iosifov
Aim: To evaluate the accuracy of a rapid test for semi-quantitative determination of NT-proBNP levels in the diagnosis of CHF in comparison with quantitative assessment; to study the strength of the association of the res...
[Evaluation of the Functional Reserve and Exercise Tolerance in Patients with CHF in Clinical Trials (Consent Document of the Editorial board of the Journal of Cardiology, the Board of the Society of Specialists in Heart Failure (SSHF) and Working Group "Non-drug treatment methods" of SSHF)] [0.03%]
[NP_reserve和运动耐力在心衰患者临床试验中的评估(日本循环器杂志编辑委员会、日本心不全専门医の会理事会及非药物治疗ワーキンググループ)]
Yu L Begrambekova,G P Arutynov,M G Glezer et al.
Yu L Begrambekova et al.
Assessing the functional capacity and exercise tolerance is an important and widely used research tool in patients with heart failure. It is used not only in cardiac rehabilitation and physical therapy, but also for inclusion criteria and o...
[Abstracts of the National Congress with International Participation "Heart Failure 2023". Moscow, December 8-9, 2023] [0.03%]
国际参与的全俄“心力衰竭2023”大会摘要莫斯科，2023年12月8日-9日
Article Editorial
Article Editorial
Abstracts of the National Congress with International Participation "Heart Failure 2023". Moscow, December 8-9, 2023.
[Cardiac Dysfunction and Arterial Hypertension as Manifestations of Cardiovasculotoxicity of iVEGF-Containing Chemotherapy. Clinical Case] [0.03%]
[与含iVEGF化疗相关的心血管毒性的两种表现：心功能不全和高血压。病例报告]
Yu Yu Kirichenko,T Yu Kulagina,O A Zhigulina et al.
Yu Yu Kirichenko et al.
Significant advances in timely diagnosis and modern antitumor therapy have led to a considerable increase in the survival rate of cancer patients. On the other hand, the incidence of cardiovascular (CV) diseases and their complications is i...
Case Reports
Kardiologiia. 2024 May 31;64(5):33-38. DOI:10.18087/cardio.2024.5.n2661 2024
[Modern Fixed Combinations in the Correction of Arterial Hypertension and Dyslipidemia] [0.03%]
现代固定复方在高血压和血脂异常治疗中的应用
Z M Galeeva,A S Galyavich,L V Baleeva et al.
Z M Galeeva et al.
Based on a clinical case report, the article shows the individual selection of effective therapy for a patient with arterial hypertension and dyslipidemia. Taking into account the risk factors for cardiovascular diseases, Equamer® was sele...
Case Reports
Kardiologiia. 2024 May 31;64(5):26-32. DOI:10.18087/cardio.2024.5.n2656 2024
A B Sugraliyev
A B Sugraliyev
The extensive use of therapeutic doses of heparin to prevent thrombosis in critically ill patients with COVID-19 during the pandemic has led to an increased incidence of bleeding and heparin-induced thrombocytopenia (HIT). In addition, the ...
Causes of Death in Patients Asking for Polyclinic Care for Coronary Heart Disease [0.03%]
冠心病门诊患者的死亡原因分析
I V Samorodskaya,O V Zayratyants,E P Kakorina et al.
I V Samorodskaya et al.
Aim: Retrospective analysis of the underlying causes for death of patients who did and did not seek outpatient medical care (OPMC) for ischemic heart disease (IHD), and discussion of a possibility for using administrative...
WNT Signaling Cascade Proteins and LRP6 in the Formation of Various Types of Coronary Lesions in Patients With Coronary Artery Disease [0.03%]
Wnt信号级联蛋白和LRP6在冠心病患者各种类型冠脉病变形成中的作用
Yu N Belenkov,A O Iusupova,O A Slepova et al.
Yu N Belenkov et al.
Aim: Assessment of WNT1, WNT3a, and LRP6 concentrations in patients with ischemic heart disease (IHD) and obstructive and non-obstructive coronary artery (CA) disease. ...
Observational Study
Kardiologiia. 2024 May 31;64(5):3-10. DOI:10.18087/cardio.2024.5.n2626 2024
[Anthracycline-induced Heart Failure: Treatment and Recovery Prospects] [0.03%]
蒽环类药物导致的心力衰竭：治疗及康复前景
M V Vitsenya,A V Potekhina,A Yu Filatova et al.
M V Vitsenya et al.
The article presents a clinical case of heart failure associated with the anthracycline-containing antitumor therapy in a breast cancer patient with an initially low risk of developing cardiovascular complications.
Case Reports
Kardiologiia. 2024 Apr 30;64(4):79-84. DOI:10.18087/cardio.2024.4.n2641 2024